Dental Care Clinics in Mountain City, TN Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Mc Dental Services Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1199 Cold Springs Rd, Mountain City, TN 37683 Phone: 423-727-0655 |
Benjamin H. Barkley Dds Mountain City Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1199 Cold Springs Rd, Mountain City, TN 37683 Phone: 423-727-0655 Fax: 423-727-0730 |
News Archive
Once-daily edoxaban prevents stroke in patients with atrial fibrillation
According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.
Parties still far apart as deficit panel eyes benefits, taxes
Media outlets report on Capitol Hill reactions to the super committee proposals and counter-proposals that surfaced this week. For instance, House Speaker John Boehner, R-Ohio, gave his "most pessimistic" take to date on whether the panel would be able to offer recommendations by Thanksgiving on how to reach the deficit-reduction target.
Specific bacteria in the intestines can improve response rate to cancer immunotherapy
In the Jan. 5, 2018 issue of Science, researchers from the University of Chicago Medicine show that specific strains of commensal bacteria – the swarms of microorganisms naturally dwelling in the intestines – can improve the response rate to immunotherapy for patients being treated for advanced melanoma.
Aceto third-quarter net sales up 24.5% to $99.3 million
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced results of operations for its fiscal 2010 third quarter and nine months ended March 31, 2010.
ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that it has submitted a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for ocriplasmin Intravitreal Injection, 2.5 mg/mL, for the treatment of symptomatic VMA including macular hole.
› Verified 8 days ago